Advanced Solid Tumors
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients who voluntarily participate in the study and have signed the written informed consent form; (2) Age >=18 years; (3) Patients with solid tumors who meet the requirements for GCP clinical trials; (4) Patients scheduled to receive intratumoral injection therapy.
Exclusion criteria
Exclusion criteria: (1)Pregnant women or patients allergic to ultrasound contrast agents; (2)Patients who have previously received intratumoral injection therapy; (3)Patients who refuse or are unable to undergo contrast-enhanced ultrasound examination; (4)Patients with incomplete clinical pathological data or ultrasound imaging data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Qualitative CEUS enhancement pattern;Quantitative CEUS parameters;Treatment response assessment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Repeat measurement consistency; | — |
Countries
China
Contacts
Langfang Campus, Cancer Hospital, Chinese Academy of Medical Sciences